FALKLAND ISLANDS

_____________

 

Misuse of Drugs (Designation) Order 1989

 

(S.R. & O. No. 5 OF 1989)

 

ARRANGEMENT OF PROVISIONS

    Paragraph

                 1.            Citation

                 2.            Designation of certain controlled drugs

                            Schedule

 

 

 

FALKLAND ISLANDS

_____________

 

Misuse of Drugs (Designation) Order 1989

 

[DATE OF COMMENCEMENT: 31ST MARCH 1989]

[Order49.3.2s1]1        Citation

This Order may be cited as the Misuse of Drugs (Designation) Order 1989.

[Order49.3.2s2]2        Designation of certain controlled drugs

(1) The controlled drugs specified in Part I of the Schedule hereto are hereby designated as drugs to which section 7(4) of the Misuse of Drugs Ordinance 1987 applies.

[Revision w.e.f. 31/07/2017]

(2) Part II of the Schedule hereto shall have effect for the purpose of specifying those controlled drugs which are excepted from Part I thereof.

SCHEDULE

PART I
CONTROLLED DRUGS TO WHICH SECTION 7(4) OF THE MISUSE OF DRUGS ORDINANCE APPLIES

1. The following substances and products, namely-

     (a)     Bufotenine

              Cannabinol

              Cannabinol derivatives

              Cannabis

              Cannabis resin

              Cathinone

              Coca Leaf

              Concentrate of poppy-straw

              Eticyclidine

              Lysergamide

              Lysergide and other N-alkyl derivatives of lysergamide

              Mescaline

              Psilocin

              Raw opium

              Rolicyclidine

              Tenocyclidine

              4-Bromo-2,5-dimethoxy-a-methyl-phenethylamine

              N,N-Diethyltryptamine

              N,N-Dimethyltryptamine

              2,5-Dimethoxy-a-,4-dimethylphenethylamine

     (b)     any compound (not being a compound for the time being specified in subparagraph (a) above) structurally derived from tryptamine or from a ringhydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

     (c)     any compound (not being methoxphenamine or a compound for the time being specified in subparagraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, a-methylphenethylamine, an N-alkyl-a-methylphenethylamine, a-ethylphenethylamine, or an N-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituent;

     (d)     any compound (not being a compound for the time being specified in Part II of this Schedule) structurally derived from fentanyl by modification in any of the following ways, that is to say-

           (i)       by replacement of the phenyl portion of the phenethyl group by any heteromomo cycle whether or not further substituted in the heterocycle;

          (ii)       by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, heloalkyl, amino or nitro groups;

         (iii)       by substitution in the piperidine ring with alkyl or alkenyl groups;

         (iv)       by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

          (v)       by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

         (vi)       by replacement of the N-propionyl group by another acyl group;

     (e)     any compound (not being a compound for the time being specified in Part II of this Schedule) that is structurally derived from pethidine by modification in any of the following ways, that is to say,

           (i)       by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

          (ii)       by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

         (iii)       by substitution of the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

         (iv)       by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

          (v)       by formation of an N-oxide or of a quaternary base.

2. Any stereoisomeric form of a substance specified in paragraph 1.

3. Any ester or ether of a substance specified in paragraph 1 or 2.

4. Any salt of a substance specified in any of paragraphs 1 to 3.

5. Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4.

PART II
CONTROLLED DRUGS EXCEPTED FROM PART I

1. The compounds referred to in paragraph 1(d) of Part I of this Schedule are-

          Alfentanil

          Carfentanil

          Lofentanil

          Sufentanil

2. The compounds referred to in paragraph 1(e) of Part I of this Schedule are-

          Allylprodine

          Alphameprodine

          Alphaprodine

          Anileridine

          Betameprodine

          Betaprodine

          Hydroxypethidine

          Properidine

          Trimeperidine